Skip to main content

Psyence Biomedical Ltd.

PBM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001985062

No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.24M in total; no superinvestor holds it.

Other share classesPBMWW

13F holders, Q1 2024

Institutional positions in Psyence Biomedical Ltd. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
10
+10 vs. Q4 2023
Shares held
741.1K
+741.1K vs. Q4 2023
Total value
$830.9K
+$830.9K vs. Q4 2023
New holders
10
0 more added
Sold out
0
0 more reduced

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PBM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 10 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 10 institutionsQ2 2024: 10 institutionsQ3 2024: 12 institutionsQ4 2024: 11 institutionsQ1 2025: 8 institutionsQ2 2025: 6 institutionsQ3 2025: 6 institutionsQ4 2025: 5 institutionsQ1 2026: 2 institutionsQ2 2026: 9 institutions
Value heldQ1 2024: $830.9K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $830.9KQ2 2024: $279.8KQ3 2024: $200.8KQ4 2024: $1.53MQ1 2025: $272.8KQ2 2025: $625.3KQ3 2025: $763.7KQ4 2025: $718.4KQ1 2026: $575.0KQ2 2026: $1.24M
Institutions holding PBM and their total value by quarter
QuarterHoldersValue
Q2 20269$1.24M
Q1 20262$575.0K
Q4 20255$718.4K
Q3 20256$763.7K
Q2 20256$625.3K
Q1 20258$272.8K
Q4 202411$1.53M
Q3 202412$200.8K
Q2 202410$279.8K
Q1 202410$830.9K
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Psyence Biomedical Ltd.; share changes are against Q4 2023.

Institutions holding PBM in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Cantor Fitzgerald, L. P.337,000$370.7K0.09%+337,000New
AdvisorShares Investments LLC271,336$309.3K0.05%+271,336New
Two Sigma Securities, LLC55,776$63.6K0.00%+55,776New
Virtu Financial LLC26,419$30.0K0.00%+26,419New
Cowen and Company, LLC25,000$28.5K0.00%+25,000New
HRT Financial LP12,611$14.0K0.00%+12,611New
Geode Capital Management, LLC10,488$12.0K0.00%+10,488New
UBS Group AG2,364$2.69K0.00%+2,364New
Headlands Technologies LLC96$1090.00%+96New
JPMorgan Chase & Co2$20.00%+2New